GATA NEWZZZ $44M IN REVS LAST YEAR!!! Groupe Athena, Inc.

New Post Public Reply Private Reply Replies (0) Message Board

Aug 22, 2012 at 1:32 PM

[b]GATA NEWZZZ >> $44M IN REVS LAST YEAR!!![/b]

Groupe Athena, Inc. Reports Audited Financials, Announces Record Revenues & Profits
Aug 22, 2012
OTC Disclosure & News Service

Mumbai, MHT, India -

Groupe Athena, Inc. (Pink sheets GATA.PK) today announced record revenues of $44,571,386 for the recent fiscal year ended June 30, 2012, an increase of 78% over the previous year. After tax earnings increased 116% to a record $4,417,047 or $0.094 a share.
The Company's Chairman, D. Purohit stated, "Though we are pleased with these results, we will continue adding more equipment and concentrate on our marketing efforts to increase revenues. As a result of these efforts, we are confident of reporting record revenues in the current fiscal year too. As many critical drug patents expire for large U.S. manufacturers, our client base is bound to increase. This is an exciting time to be part of our dynamic revenue growth and we look forward to increasing our market share in the Indian pharmaceutical industry."
Though the company added $4,656,442 in assets, it’s cash positionis extremely healthy with cash and short term assets of $ 3,286,141 as againstcurrent liabilities of $ 84,090. The company is proud of the fact that all equipment and other acquisitions have been made entirely from internally generated cash and it is the commitment of management that future additions to the asset base be accomplished without any further dilution or debt increases.The Company has no plans for shareholder dilution over the next 12-18 months.
To read the complete quarterly report, please go to www.otcmarkets.com and enter the company's trading symbol"GATA"
About Groupe Athena, Inc.
Groupe Athena Inc. was incorporated in June 2008 and began operations on July 1 of that year. The company is aresearch and testing organization and helps various pharmaceutical and medicalproducts and devices companies in India and Southeast Asia toget regulatory approvals and facilitate exports of their products to the United States.The Company accomplishes this by assisting clients from concept throughdevelopment, providing consultation on regulatory requirements, filings andprocesses.
The company has a research and marketing facility in India that currently employs 17 consultantsand marketing personnel and is working towards aggressively expanding itspresence in the Indian pharmaceutical industry. The Company's web address is www.groupeathena.com
Safe Harbor Statement
Certain statements set forth in this press release constitute"forward-looking statements." Forward-looking statements include,without limitation, any statement that may predict, forecast, indicate, orimply future results, performance or achievements, and may contain the words"estimate", "project", "intend","forecast", "anticipate", "plan","planning", "expect", "believe", "willlikely", "should", "could", "would","may" or words or expressions of similar meaning. Such statements arenot guarantees of future performance and are subject to risks and uncertaintiesthat could cause the company's actual results and financial position to differmaterially from those included within the forward-looking statements.Forward-looking statements involve risks and uncertainties, including thoserelating to the Company's ability to grow its business. Actual results maydiffer materially from the results predicted and reported results should not beconsidered as an indication of future performance. The potential risks anduncertainties include, among others, the Company's limited operating history,the limited financial resources, domestic or global economic conditions --activities of competitors and the presence of new or additional competition andconditions of equity markets.

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

IASO's FUCASO Shows Robust Results in 2026 Study

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Melrose Fire Station Reaches Steel Topping Milestone

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

DKS Facing Class Action Over Stock Slump Allegations

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Quay Shines in 2026 Prescription Sunglasses Lineup

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Salveo Home Care Faces Class Action Over Labor Violations

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...